⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1189276 | 0.89 | — | — | |
| SCHEMBL1190894 | 0.85 | — | — | |
| SCHEMBL1189903 | 0.85 | — | — | |
| SCHEMBL1190734 | 0.82 | CDC7 (0.47) | — | |
| SCHEMBL1191296 | 0.82 | — | — | |
| SCHEMBL1191185 | 0.81 | — | — | |
| SCHEMBL1190927 | 0.81 | — | — | |
| SCHEMBL1189118 | 0.81 | PRKAG1 (0.57) | — | |
| SCHEMBL1191362 | 0.79 | PRKAG1 (0.53) | — | |
| SCHEMBL1190926 | 0.79 | PRKAG1 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110034505-A1 | THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS | MERCK PATENT GESELLSCHAFT (DE) | 2011-02-10 | — | — | US | claimed |
| EP-2262500-A1 | THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS | Merck Patent GmbH (DE) | 2010-12-22 | — | — | EP | claimed |
| WO-2009124636-A1 | THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS | MERCK PATENT GMBH (DE) | 2009-10-15 | — | — | WO | claimed |
| US-8563729-B2 | Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators | MERCK PATENT GMBH (DE) | 2013-10-22 | — | — | US | disclosed |
| US-20110034505-A1 | THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS | MERCK PATENT GESELLSCHAFT (DE) | 2011-02-10 | — | — | US | disclosed |